z-logo
open-access-imgOpen Access
High-dose dual therapy versus bismuth-containing quadruple therapy for the treatment of Helicobacter pylori infection – A review of the strengths, weaknesses, and proposed solutions
Author(s) -
Chi-Tan Hu
Publication year - 2022
Publication title -
tzu-chi medical journal/cí-jì yīxué
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.343
H-Index - 15
eISSN - 2223-8956
pISSN - 1016-3190
DOI - 10.4103/tcmj.tcmj_185_21
Subject(s) - medicine , metronidazole , helicobacter pylori , amoxicillin , omeprazole , clarithromycin , regimen , gastroenterology , adverse effect , proton pump inhibitor , helicobacter , pharmacotherapy , antibiotics , bismuth , microbiology and biotechnology , materials science , metallurgy , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here